Kozak & Associates »

United Therapeutics Corporation shares owned by Kozak & Associates

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Kozak & Associates from 13F filings

Historical chart of Kozak & Associates investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Kozak & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Kozak & Associates

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.5k 21 311.05
2024-03-31 $5.7k 21 272.24

More positions owned by Kozak & Associates

Ishares U.s. Tech Independence Focused Etf Etf (IETC)
Spdr S&p 500 Etf Trust Etf (SPY)
Invesco S&p 500 Revenue Etf Etf (RWL)
Invesco Qqq Trust Series I Etf (QQQ)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Ishares Us Financial Services Etf Etf (IYG)
Costco Whsl Corp Stock (COST)
Amazon Stock (AMZN)
Vaneck Semiconductor Etf Etf (SMH)
Health Care Select Sector Spdr Fund Etf (XLV)
Schwab Charles Corp Stock (SCHW)
Deere & Co Stock (DE)

View all positions for Kozak & Associates

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Citigroup
Geode Capital Management
FMR
LSV Asset Management
Morgan Stanley
AQR Capital Management
Dimensional Fund Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation